These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. On the role of folate deficiency in cancer therapy. Cohen P; Dix D Clin Chem; 1988 Sep; 34(9):1945-6. PubMed ID: 3416476 [No Abstract] [Full Text] [Related]
64. Physical illness and depression: the effects of acute physical illness on the mental state of psychiatric inpatients. Deahl MP Acta Psychiatr Scand; 1990 Jan; 81(1):83-6. PubMed ID: 2330835 [TBL] [Abstract][Full Text] [Related]
65. Depression in schizophrenia. Richman N Br J Psychiatry; 1986 Dec; 149():797. PubMed ID: 3790886 [No Abstract] [Full Text] [Related]
66. L-methylfolate cannot yet be recommended as an add-on treatment in schizophrenia. Misiak B Evid Based Ment Health; 2018 Feb; 21(1):e6. PubMed ID: 29212788 [No Abstract] [Full Text] [Related]
67. Active Folate Versus Folic Acid: The Role of 5-MTHF (Methylfolate) in Human Health. Carboni L Integr Med (Encinitas); 2022 Jul; 21(3):36-41. PubMed ID: 35999905 [No Abstract] [Full Text] [Related]
68. Multivitamin Supplementation During Pregnancy: Emphasis on Folic Acid and l-Methylfolate. Greenberg JA; Bell SJ Rev Obstet Gynecol; 2011; 4(3-4):126-7. PubMed ID: 22229066 [No Abstract] [Full Text] [Related]
69. L-Methylfolate as a Monotherapy for Treatment-Resistant Depression: A Case Study. Hardin A; Baldwin-Sayre C Integr Med (Encinitas); 2020 Aug; 19(4):14-18. PubMed ID: 33132780 [TBL] [Abstract][Full Text] [Related]
70. Enhancement of recovery from psychiatric illness by methylfolate. Godfrey PS; Toone BK; Carney MW; Flynn TG; Bottiglieri T; Laundy M; Chanarin I; Reynolds EH Lancet; 1990 Aug; 336(8712):392-5. PubMed ID: 1974941 [TBL] [Abstract][Full Text] [Related]
71. Effect of long-term supplementation with folic acid and B vitamins on risk of depression in older women. Okereke OI; Cook NR; Albert CM; Van Denburgh M; Buring JE; Manson JE Br J Psychiatry; 2015 Apr; 206(4):324-31. PubMed ID: 25573400 [TBL] [Abstract][Full Text] [Related]
72. L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials. Papakostas GI; Shelton RC; Zajecka JM; Etemad B; Rickels K; Clain A; Baer L; Dalton ED; Sacco GR; Schoenfeld D; Pencina M; Meisner A; Bottiglieri T; Nelson E; Mischoulon D; Alpert JE; Barbee JG; Zisook S; Fava M Am J Psychiatry; 2012 Dec; 169(12):1267-74. PubMed ID: 23212058 [TBL] [Abstract][Full Text] [Related]
73. Effect of adjunctive L-methylfolate 15 mg among inadequate responders to SSRIs in depressed patients who were stratified by biomarker levels and genotype: results from a randomized clinical trial. Papakostas GI; Shelton RC; Zajecka JM; Bottiglieri T; Roffman J; Cassiello C; Stahl SM; Fava M J Clin Psychiatry; 2014 Aug; 75(8):855-63. PubMed ID: 24813065 [TBL] [Abstract][Full Text] [Related]
76. Assessing Effects of l-Methylfolate in Depression Management: Results of a Real-World Patient Experience Trial. Shelton RC; Sloan Manning J; Barrentine LW; Tipa EV Prim Care Companion CNS Disord; 2013; 15(4):. PubMed ID: 24392264 [TBL] [Abstract][Full Text] [Related]
77. Comparative assessment of adherence measures and resource use in SSRI/SNRI-treated patients with depression using second-generation antipsychotics or L-methylfolate as adjunctive therapy. Wade RL; Kindermann SL; Hou Q; Thase ME J Manag Care Pharm; 2014 Jan; 20(1):76-85. PubMed ID: 24372461 [TBL] [Abstract][Full Text] [Related]
78. Higher dose L-methylfolate may be an effective adjunctive therapy for adults with major depression who have inadequate response to SSRIs. Roberts SH; Tranter R Evid Based Ment Health; 2013 Aug; 16(3):75. PubMed ID: 23625145 [No Abstract] [Full Text] [Related]
79. S-Adenosyl Methionine and Transmethylation Pathways in Neuropsychiatric Diseases Throughout Life. Gao J; Cahill CM; Huang X; Roffman JL; Lamon-Fava S; Fava M; Mischoulon D; Rogers JT Neurotherapeutics; 2018 Jan; 15(1):156-175. PubMed ID: 29340929 [TBL] [Abstract][Full Text] [Related]
80. A randomised double-blind placebo-controlled 12- week feasibility trial of methotrexate added to treatment as usual in early schizophrenia: study protocol for a randomised controlled trial. Chaudhry IB; Husain N; ur Rahman R; Husain MO; Hamirani MM; Kazmi A; Baig S; Haddad PM; Buch MH; Qureshi I; Mehmood N; Kiran T; Fu B; Afsar S; Deakin B Trials; 2015 Jan; 16():9. PubMed ID: 25563714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]